Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy
Biomedical Optics Express · 01.01.2024 · 15 (1) · 59
DOI: 10.1364/boe.499286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Optics Express, online erschienen am 06.12.2023. Verfasst von Qiang Xue und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shenzhen People's Hospital, The Second Clinical College of Jinan University, The First Affiliated Hospital of Southern Univ…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypoxia is a critical tumor microenvironment (TME) component. It significantly impacts tumor growth and metastasis and is known to be a major obstacle for cancer therapy. Integrating hypoxia modulation with imaging-based monitoring represents a promising strategy that holds the potential for enhancing tumor theranostics. Herein, a kind of nanoenzyme Prussian blue (PB) is synthesized as a metal-organic framework (MOF) to load the second near-infrared (NIR-II) small molecule dye IR1061, which could catalyze hydrogen peroxide to produce oxygen and provide a photothermal conversion element for photoacoustic imaging (PAI) and photothermal therapy (PTT). To enhance stability and biocompatibility, silica was used as a coating for an integrated nanoplatform (SPI). SPI was found to relieve the hypoxic nature of the TME effectively, thus suppressing tumor cell migration and downregulating the expression of heat shock protein 70 (HSP70), both of which led to an amplified NIR-II PTT effect in vitro and in vivo, guided by the NIR-II PAI. Furthermore, label-free multi-spectral PAI permitted the real-time evaluation of SPI as a putative tumor treatment. A clinical histological analysis confirmed the amplified treatment effect. Hence, SPI combined with PAI could offer a new approach for tumor diagnosing, treating, and monitoring.
Autor:innen und Institutionen
- Department of Ultrasound, Shenzhen People's Hospital, The Second Clinical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.
- Research Center for Biomedical Optics and Molecular Imaging, Key Laboratory of Biomedical Imaging Science and System, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
- Department of Medical Ultrasonics, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- The University of Hong Kong, Department of Electrical and Electronic Engineering, Hong Kong, China.
- Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou 310014, China.
ORCID-Profile: Ningbo Chen, Kenneth K Y Wong, Chengbo Liu, Jingqin Chen
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Xue, Q., Zeng, S., Ren, Y., Pan, Y., Chen, J., Chen, N., Wong, K. K. Y., Song, L., Fang, C., Guo, J., Xu, J., Liu, C., Zeng, J., Sun, L., Zhang, H., & Chen, J. (2024). Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy. Biomedical Optics Express, 15(1), 59. https://doi.org/10.1364/boe.499286
Vancouver
Xue Q, Zeng S, Ren Y, Pan Y, Chen J, Chen N, et al. Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy. Biomedical Optics Express. 2024;15(1):59. doi:10.1364/boe.499286
BibTeX
@article{Xue2024,
author = {Xue, Qiang and Zeng, Silue and Ren, Yaguang and Pan, Yingying and Chen, Jianhai and Chen, Ningbo and Wong, Kenneth K Y and Song, Liang and Fang, Chihua and Guo, Jinhan and Xu, Jinfeng and Liu, Chengbo and Zeng, Jie and Sun, Litao and Zhang, Hai and Chen, Jingqin},
title = {Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy},
journal = {Biomedical Optics Express},
year = {2024},
volume = {15},
number = {1},
pages = {59},
doi = {10.1364/boe.499286}
}
EUVIMED